Literature DB >> 6116307

The role of gastrin in duodenal ulcer.

J E McGuigan, R F Harty, D G Maico.   

Abstract

It is now evident that hypersecretion of gastric hydrochloric acid is an important pathogenetic element among a variety of heterogeneous factors responsible for the production of common duodenal ulcer. Hypersecretion of gastric acid due to usually strikingly increased circulating levels of gastrin released from gastrinoma tissue is characteristics of patients with to Zollinger-Ellison Syndrome. In contrast, fasting serum gastrin levels are normal in patients with common duodenal ulcer. The polypeptide hormone, gastrin does, however, appear to play subtle and multiple roles in enhancement of gastric acid secretion in duodenal ulcer. Recent evidence suggests that abnormalities in gastrin release and action may be influenced by participation of somatostatin. The hypothesis is proposed for consideration and for further investigation that the multiple subtle abnormalities in gastrin release and parietal cell sensitivity to gastrin may be due to disturbances in the actions or concentrations of locally acting polypeptides, substances which are capable of suppressing gastrin release and its effects (somatostatin), or alternatively, are capable of stimulating release of gastrin into the circulation (bombesin).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116307      PMCID: PMC2279490     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  26 in total

1.  THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA.

Authors:  R A GREGORY; H J TRACY
Journal:  Gut       Date:  1964-04       Impact factor: 23.059

2.  THE ANTRAL HORMONE GASTRIN. STRUCTURE OF GASTRIN.

Authors:  H GREGORY; P M HARDY; D S JONES; G W KENNER; R C SHEPPARD
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

3.  Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.

Authors:  S R Bloom; C H Mortimer; M O Thorner; G M Besser; R Hall; A Gomez-Pan; V M Roy; R C Russell; D H Coy; A J Kastin; A V Schally
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

4.  Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells.

Authors:  J M Polak; A G Pearse; L Grimelius; S R Bloom
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

Review 5.  Peptic ulcer disease--a heterogeneous group of disorders?

Authors:  J I Rotter; D L Rimoin
Journal:  Gastroenterology       Date:  1977-09       Impact factor: 22.682

6.  Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.

Authors:  S J Konturek; J Tasler; M Cieszkowski; D H Coy; A V Schally
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

7.  Studies on duodenal ulcer. I. The clinical evidence for the existence of two populations.

Authors:  S K Lam; W Sircus
Journal:  Q J Med       Date:  1975-04

8.  Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients.

Authors:  J F Rehfeld; F Stadil
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

9.  Somatostatin in mucosa of stomach and duodenum in gastroduodenal disease.

Authors:  J A Chayvialle; F Descos; C Bernard; A Martin; C Barbe; C Partensky
Journal:  Gastroenterology       Date:  1978-07       Impact factor: 22.682

10.  Immunoreactive gastrin components in human serum.

Authors:  J F Rehfeld; F Stadil; J Vikelsoe
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.